Eledon Pharmaceuticals Inc (NASDAQ: ELDN) is -1.70% lower on its value in year-to-date trading and has touched a low of $1.52 and a high of $5.54 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The ELDN stock was last observed hovering at around $3.71 in the last trading session, with the day’s gains setting it 0.34%.
Currently trading at $4.05, the stock is -5.19% and -8.11% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 0.99 million and changing 9.16% at the moment leaves the stock 32.28% off its SMA200. ELDN registered 134.09% gain for a year compared to 6-month gain of 43.11%. The firm has a 50-day simple moving average (SMA 50) of $4.4193 and a 200-day simple moving average (SMA200) of $3.05165.
The stock witnessed a -7.95% loss in the last 1 month and extending the period to 3 months gives it a 47.27%, and is -10.20% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 8.22% over the week and 8.50% over the month.
Eledon Pharmaceuticals Inc (ELDN) has around 20 employees, a market worth around $241.94M and $0.00M in sales. Distance from 52-week low is 166.46% and -26.90% from its 52-week high. The company has generated returns on investments over the last 12 months (-130.87%).
The EPS is expected to grow by 51.83% this year
The shares outstanding are 59.74M, and float is at 57.06M with Short Float at 2.19%.
The top institutional shareholder in the company is BVF INC/IL with over 6.29 million shares valued at $16.61 million. The investor’s holdings represent 20.985 of the ELDN Shares outstanding. As of 2024-06-30, the second largest holder is ARMISTICE CAPITAL, LLC with 2.34 million shares valued at $6.17 million to account for 7.7894 of the shares outstanding. The other top investors are ZIMMER PARTNERS, LP which holds 2.11 million shares representing 7.0348 and valued at over $5.57 million, while SCHONFELD STRATEGIC ADVISORS LLC holds 5.0018 of the shares totaling 1.5 million with a market value of $3.96 million.
